Effectiveness and Safety of Adjuvant Software Based on Virtual Reality for Post-thoracoscopic Surgery Pain

Exclusion Criteria13

• Patients with severe cognitive impairment.
• Patients with a previous diagnosis of epilepsy, dementia, migraine, or other neurological disease that may result in the inability to use postoperative analgesic adjuvant therapy software or that may have adverse effects.
• Patients who are unable to understand or speak Mandarin.
• Patients who have visual abnormalities, severe hearing impairment, or motion sickness, etc., and are unable to view VR.
• Patients with trauma to the eyes, face, or neck that prevents the comfortable use of the VR device.
• Patients with severe heart, liver, kidney, hematologic, digestive, nervous system diseases and malnutrition.
• Patients who have previously used virtual reality software for pain that has not responded to treatment.
• Patients with a history of severe alcohol abuse, long-term heavy drinking, and symptoms of alcohol dependence.
• Patients who have participated in any analgesic interventional study within the past 1 week.
• Females who are pregnant or plan to become pregnant during the study.
• The patient or their immediate family member works for a digital health or pharmaceutical company for acute or chronic pain treatment.
• Patients who are unable to use electronic devices such as smartphones.
• Other conditions that the investigator considers inappropriate for participation in a clinical trial.